Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower the risk of opioid addiction in men taking opioids.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Finasteride may help reduce opioid use.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

The compound 4c showed strong potential as an anticancer agent.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Oral contraceptives can affect skin and hair, improve acne, but may cause pigmentation, dermatitis, and other conditions.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

A blood pressure drug, diltiazem, may also help treat influenza.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Deoxycorticosterone and its metabolites help prevent seizures by interacting with specific receptors.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.